VolparaEnterprise software provides ConstantQuality metrics and breast-specific key performance indicators to help your team perform at its very best, delivering the highest-quality breast imaging services.

Learn more about VolparaEnterprise

VolparaEnterprise Clinical Applications provide quick, automated assessment of every exam, producing a Volpara Scorecard that includes VolparaDensity, VolparaDose, and VolparaPressure.

Learn more about VolparaEnterprise DDP

VolparaDensity provides fast, objective assessment of a woman’s breast density from most digital mammography and tomosynthesis vendors.

Learn more about VolparaDensity

About Volpara Solutions

Volpara Solutions Limited is the wholly-owned sales and marketing arm of Volpara Health Technologies Limited – an ISO13485 and ISO27001 certified, ISO14971, FDA GMP compliant research, development and manufacturing company that develops digital health solutions to enable personalized, high-quality breast cancer screening based on objective measurements of breast density, compression and radiation dose.

10,000,000
Women Scanned
180
Research Publications
155
Facilities
35
Countries

Researching? Check out our Science Hub

Volpara is the tool of choice for many researchers around the world. The Volpara suite of products provides ongoing information for improving clinical screening to population characteristics and breast cancer risk.

Research Review

Breast density is gaining increasing attention in research, legislation and the clinic. These latest peer-reviewed publications deliver insight into understanding and managing breast density.

Upcoming Events

European Congress of Radiology 2018

28 February 2018

Meet our European team in Vienna for live demonstrations of VolparaEnterprise.

Read more

National Consortium of Breast Centers

9 March 2018

Learn more about VolparaEnterprise at NCoBC in Las Vegas.

Read more